Long-Term Effect of High-Dose Dexamethasone with or without Low-Dose Dexamethasone Maintenance in Untreated Immune Thrombocytopenia

被引：38
|
作者：
Din, Banhe [1 ]
Wang, Xingwen [2 ]
Shi, Yuye [1 ]
Li, Yufeng [1 ]
机构：
[1] Nanjing Med Univ, Huaian Peoples Hosp 1, Dept Hematol, Huaian 223300, Jiangsu, Peoples R China
[2] Nanjing Med Univ, Huaian Peoples Hosp 1, Dept Pharmaceut, Huaian 223300, Jiangsu, Peoples R China
来源：
ACTA HAEMATOLOGICA | 2015年 / 133卷 / 01期
关键词：
High-dose dexamethasone; Immune thrombocytopenia; Long-term efficacy; Maintenance therapy; PURPURA; CHILDREN; ADULTS; THERAPY;
D O I：
10.1159/000362529
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Background: To tackle the problems associated with high-dose dexamethasone (HD-DXM) in patients with immune thrombocytopenia (ITP). Aim: To compare the efficacy of HD-DXM with or without low-dose dexamethasone maintenance in untreated ITP patients. Results: Dexamethasone (40 mg/day) was given in 4-day pulses every 14 days for 3 cycles in 61 patients with ITP. Among them, 30 cases were given dexamethasone (0.035 mg/kg per day) for maintenance between pulsed HD-DXM and after 3 HD-DXM courses (HD-DXM-M group) and another 31 cases did not receive dexamethasone maintenance (HD-DXM-nM group). The control group comprised the patients who received prednisone (prednisone group). The following results were obtained: (1) at the end of the 3rd cycle, the overall response rate (ORR) was higher in the HD-DXM group than in the prednisone group; (2) the ORR of the HD-DXM group peaked after the 3rd cycle; (3) the ORR after each course was higher in the HD-DXM-M group than in the HD-DXM-nM group; (4) in the 12th month after HD-DXM discontinuation, the relapse rate of the HD-DXM-M group was lower than that of the other groups (prednisone and HD-DXM-nM). Conclusion: Treatment with 3 cycles of HD-DXM pulses with low-dose dexamethasone maintenance is an effective method for untreated ITP. (C) 2014 S. Karger AG, Basel
引用
收藏
页码：124 / 128
页数：5
相关论文
共 50 条
  • [31] HIGH-DOSE VERSUS LOW-DOSE DEXAMETHASONE IN EXPERIMENTAL EPIDURAL SPINAL-CORD COMPRESSION
    DELATTRE, JY
    ARBIT, E
    ROSENBLUM, MK
    THALER, HT
    LAU, N
    GALICICH, JH
    POSNER, JB
    NEUROSURGERY, 1988, 22 (06) : 1005 - 1007
  • [32] CYTOGENETICS AND LONG-TERM SURVIVAL IN MM-003, A PHASE 3 TRIAL OF POMALIDOMIDE plus LOW-DOSE DEXAMETHASONE VS. HIGH-DOSE DEXAMETHASONE IN REFRACTORY OR RELAPSED AND REFRACTORY MULTIPLE MYELOMA
    Dimopoulos, M. A.
    Weisel, K.
    Song, K. W.
    Delforge, M.
    Karlin, L.
    Goldschmidt, H.
    Moreau, P.
    Banos, A.
    Oriol, A.
    Garderet, L.
    Cavo, M.
    Ivanova, V.
    Alegre, A.
    Martinez-Lopez, J.
    Chen, C. I.
    Spencer, A.
    Knop, S.
    Bahlis, N. J.
    Renner, C.
    Yu, X.
    Hong, K.
    Sternas, L.
    Jacques, C.
    Zaki, M. H.
    San Miguel, J. F.
    HAEMATOLOGICA, 2014, 99 : 365 - 365
  • [33] HIGH-DOSE DEXAMETHASONE AND HIGH-DOSE METOCLOPRAMIDE VERSUS HIGH-DOSE DEXAMETHASONE AND SULPIRIDE IN THE MANAGEMENT OF CISPLATIN-INDUCED EMESIS
    ROSENBLATT, E
    LEV, LM
    ROBINSON, E
    ONCOLOGY, 1988, 45 (04) : 297 - 299
  • [34] Primary Therapy with Lenalidomide plus Low-Dose Dexamethasone Versus High-Dose Dexamethasone: Update of the E4A03 Trial
    不详
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 (02): : 125 - 126
  • [35] Prolonged low-dose dexamethasone, in early gestation, has no long-term deleterious effect on normal ovine fetuses
    Moritz, K
    Butkus, A
    Hantzis, V
    Peers, A
    Wintour, EM
    Dodic, M
    ENDOCRINOLOGY, 2002, 143 (04) : 1159 - 1165
  • [36] Long-term outcomes and cost effectiveness of high-dose dexamethasone for cardiac surgery: a randomised trial
    Dieleman, J. M.
    de Wit, G. A.
    Nierich, A. P.
    Rosseel, P. M.
    van der Maaten, J. M.
    Hofland, J.
    Diephuis, J. C.
    de Lange, F.
    Boer, C.
    Neslo, R. E.
    Moons, K. G.
    van Herwerden, L. A.
    Tijssen, J. G.
    Kalkman, C. J.
    van Dijk, D.
    ANAESTHESIA, 2017, 72 (06) : 704 - 713
  • [37] High-Dose Dexamethasone Alters the Increase in Interleukin-16 Level in Adult Immune Thrombocytopenia
    Wang, Xinru
    Li, Lizhen
    Wang, Yuanjian
    Li, Xin
    Feng, Qi
    Hou, Yu
    Ma, Chunhong
    Gao, Chengjiang
    Hou, Ming
    Peng, Jun
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [38] Chemoresistant Myeloma: Phase II Clinical Study with Low-Dose Thalidomide Plus High-Dose Dexamethasone
    Bernardeschi, P.
    Dentico, P.
    Rossi, S.
    Fiorentini, G.
    Giustarini, G.
    Montenora, I.
    Turano, E.
    JOURNAL OF CHEMOTHERAPY, 2004, 16 : 90 - 93
  • [39] LONG-TERM TREATMENT WITH HIGH-DOSE AND LOW-DOSE OF ISOSORBIDEDINITRATE AFTER MYOCARDIAL-INFARCTION
    KOBER, G
    BETTINGER, R
    KLEPZIG, H
    BURGER, W
    SCHRADER, R
    KADEL, C
    FUCHS, H
    MORAWE, G
    KALTENBACH, M
    ZEITSCHRIFT FUR KARDIOLOGIE, 1989, 78 : 122 - 126
  • [40] LONG-TERM FOLLOW-UP OF CLIENTS OF HIGH-DOSE AND LOW-DOSE METHADONE PROGRAMS
    MCGLOTHLIN, WH
    ANGLIN, MD
    ARCHIVES OF GENERAL PSYCHIATRY, 1981, 38 (09) : 1055 - 1063
12345